Meral Beksac, Alessandro Corso, Joshua Ryan Richter, Nick Ballew, Vinay Jadhav, Molly Purser, Simon McNamara, Sandhya Sapra, Marius Sieverding, Zhaohui Wang, Gbenga Kazeem. "Belantamab mafodotin + pomalidomide + dexamethasone (BPd) vs daratumumab + bortezomib + dexamethasone (DVd) in relapsed/refractory multiple myeloma: An indirect comparison using patient-level data.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7536